Enoxaparin sodium yog qhov hnyav molecular hnyav heparin npaj, uas tuaj yeem ua rau qhov sib piv ntawm cov tshuaj tiv thaiv coagulant Ⅹa thiab Ⅱa kev ua haujlwm ntau dua 4, yog li ua rau muaj zog antithrombotic muaj nuj nqi thiab qee yam thrombolytic nyhuv. Tsis muaj qhov hloov pauv loj ntawm tag nrho cov coagulation Performance index ntawm cov koob tshuaj pom zoo, thiab lub sij hawm platelet aggregation thiab khi rau fibrinogen kuj tsis hloov. Txawm hais tias tsis tshua muaj molecular hnyav heparin (LMWH) yog haum rau tag nrho cov kab mob heparin nrog ib qho hnyav molecular tsawg dua 8000 Da, cov nyhuv ntawm txhua feem tseem nyob ntawm qhov hnyav molecular. Cov kev tshawb fawb hauv vitro piv rau enoxaparin sodium (molecular hnyav 4000 ~ 6000 Da) thiab unsolated heparin pom tau tias raws li lawv qhov hnyav molecular, piv nrog cov nyhuv ntawm unisolated heparin, inhibitory nyhuv ntawm enoxaparin sodium ntawm thrombin raug txo los ntawm kwv yees li 5 zaug. Hauv kev tshawb fawb vivo kuj tau pom tias daim ntawv thov subcutaneous ntawm heparin, lub sijhawm ua haujlwm ib nrab thromboplastin (APTT) yog qhov ntev dua li subcutaneous thov ntawm enoxaparin sodium.

